Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer's disease

Rona Baron1, Alicia A Babcock, Anna Nemirovsky

  • 1The Shraga Segal Department of Microbiology and Immunology, Faculty of Health Sciences and the National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.

Aging Cell
|March 20, 2014
PubMed

Insights

Aging and Alzheimer's disease impair microglia's ability to scan the brain. These immune cells lose their complex structures, reducing their surveillance capacity and potentially worsening cognitive decline.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells in the central nervous system.
  • They possess a ramified morphology essential for surveying the neuronal environment.
  • Aging and neurodegenerative diseases like Alzheimer's disease (AD) are known to affect microglial function.

Purpose of the Study:

  • To quantitatively characterize microglial morphology in aging and Alzheimer's-like disease mouse models.
  • To investigate the impact of aging and AD on microglial surveillance capacity.
  • To explore microglial phenotypes near amyloid plaques.

Main Methods:

  • Quantitative morphometric analysis of cortical microglia using a digital tool.
  • Comparison of microglial structures in young, aged, and AD model mice.
  • Assessment of proinflammatory cytokine expression.
  • Analysis of microglial process coverage of brain parenchyma.

Main Results:

  • Aged mice exhibited reduced microglial ramification, fewer branches, and decreased fine processes compared to young mice.
  • A similar, but accelerated, microglial pathology was observed in AD models.
  • Microglia near amyloid plaques displayed altered phenotypes with reduced process complexity.
  • Aging led to a significant reduction in microglial environmental scanning capacity, exacerbated in AD models.

Conclusions:

  • Aging impairs microglial surveillance due to reduced process complexity and increased inflammation.
  • This microglial pathology is accelerated in Alzheimer's disease models, leading to significant process deficiency.
  • The findings suggest a link between impaired microglial function, chronic inflammation, and cognitive decline in aging and AD.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K